Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 6428
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
70898
copy of my PM .. just now .. to another IPIX
(13)
4kids
11/18/2021 11:19:21 AM
70897
As noted previously, trial analysis is "ongoing"
(3)
bandg
11/18/2021 11:03:44 AM
70896
Update out
stocker11
11/18/2021 8:38:53 AM
70895
Innovation Pharmaceuticals Provides Brilacidin
(4)
bettingbig
11/18/2021 8:38:01 AM
70892
"...Florida teacher hospitalized with COVID-19
(2)
farrell
11/16/2021 2:07:28 PM
70891
No way to know that all analysis has been
(5)
bandg
11/16/2021 11:04:31 AM
70890
The CRO is doing/has completed all the data
(3)
petemantx
11/16/2021 10:53:53 AM
70889
Heparin interacts with the main protease of
Boneysteak
11/16/2021 6:23:50 AM
70888
While most of us view them as the elephant in the
(8)
DrTim
11/15/2021 7:45:18 PM
70886
LOL - That's about PAR for the course. Don't know
NotRichYet2
11/15/2021 11:21:58 AM
70885
He's a Big Pharma insider who will continue
(2)
Drano
11/15/2021 11:07:27 AM
Newer
Older
Recent Articles
Fluor Corporation Faces Class Action Lawsuit: What You Need to Know
Why Oklo Stock is Soaring This Week and What to Expect
Transforming $1000 in Spotify Technology into Substantial Gains
Understanding MPLX's P/E Ratio and Market Performance Today
New Hope for Ulcerative Colitis Patients with TREMFYA Approval
Exploring Recent Trends in Intel's Options Market Activity
CoreWeave Options Trading Insight: Trends to Watch in 2025
Decoding Options Trading Trends for Alibaba Group Holdings
InterCure's Strategic Acquisition Expands US Market Footprint
Exciting New Housing Project for Seniors to Enhance Community Living
Hess Midstream Adjusts Projections as Chevron Cuts Bakken Activity
Massive Jackpot Win at Legendz Casino Changes Player's Life
Nexus Capital Management Secures $1.4 Billion for Fund IV
Exploring the Expansive Growth of the SCADA System Market
Liver Cancer Therapeutics: A Market Poised for Transformation
Rising Veterinary Monoclonal Antibodies Market to Achieve $3.06 Billion
Mountain Life Insurance Streamlines Processes with New Tech
Bone Grafts and Substitutes Market Growth and Innovations Ahead
Unlocking Future Growth in Maternal Mental Health Solutions
Exploring the Growth of the Automotive Rubber-Molded Sector
Innovations in PET/EVOH/PE Packaging and Market Trends Insights
CreateFun Inspires Innovation at WOW Summit in Hong Kong
Brookfield Wealth Solutions Secures Shareholder Approval for Just
Trust Stamp Expands Partnership with Major Financial Client
Nukkleus Inc. Unlocks $250 Million for Aerospace and Defense Growth
Potts Law Firm Champions Local Businesses in Water Billing Case
Brookfield Wealth Solutions Moves Forward with Major Acquisition
Hola Prime Introduces Tradelocker to Revolutionize Trading
Micro1 Emerges as a Significant Player in AI Training Market
Rick Haase Celebrated for Outstanding Leadership in Real Estate
Miami-Dade Schools Collaborate with New Classrooms for Innovation
Monthly Distribution Announcement from PermRock Royalty Trust
ALLSWIFIT Launches Innovative Sneakers for Everyday Performance
Synopsys Faces Significant Setbacks Following Recent Earnings Report
Falcon Finance Introduces Innovative Framework for $FF Token
CATL Partners with Springer Nature for Sustainable Energy Journal Launch
ISS Concludes a Significant Annual Contract Worth DKK 100M
Sonnet BioTherapeutics Unveils Strategy at Key Industry Event
Jumpstart Agent Showcases AI Solutions at Dreamforce Event
Bit Soft Joins Forces with Volaris Group for Growth
Replimune Shares Plunge: Investors React to FDA Setback
WeRide Inc's Groundbreaking Robobus Set for Belgium Launch
Sable Offshore (SOC) Investors Face Legal Challenges Over Misleading Claims
Lockheed Martin Faces Securities Lawsuit Amid Operational Losses
Cinemark Enhances Engagement with Rokt's AI-Powered Technology
Invest in the Future: XRP Tundra's Presale at Just $0.01
Abcourt Mines Inc. Expands Financing and Royalty Buy-Back Plans
Nedap Enhances Italian Operations to Elevate Retail Experience
Empowering Women in Racing: SEGG Media Joins the Fight
Insight into Middlefield Canadian Income PCC’s Net Asset Value